What factor determines whether to use a urea breath test, stool antigen test, or esophagogastroduodenoscopy with biopsy for Helicobacter pylori detection, and how long must proton‑pump inhibitors be discontinued before each test?

H. Pylori Testing Selection and PPI Discontinuation

Stop PPIs for 2 weeks before performing urea breath tests, stool antigen tests, or endoscopic biopsy-based tests (rapid urease test, histology, culture); if stopping PPIs is not feasible, use validated IgG serology instead, as it is unaffected by PPI therapy. 1

PPI Discontinuation Requirements

Standard Recommendation Across All Active Tests

• Discontinue PPIs for 2 weeks (14 days) before testing with urea breath test (UBT), stool antigen test (SAT), rapid urease test, histology, or culture 1
• This washout period allows H. pylori to repopulate the stomach after PPI-induced suppression 1
• PPIs increase gastric pH, causing bacterial load to decrease (especially in the antrum), leading to 10-40% false-negative rates on UBT and similar rates on other active tests 1

Test-Specific Considerations

Urea Breath Test:

• Most extensively studied regarding PPI interference 1
• After stopping PPIs, 91% of tests revert to positive by day 3,97% by day 7, and 100% by day 14 2
• The 2-week discontinuation is essential for reliable results 2

Stool Antigen Test:

• Also affected by PPIs, though some newer assays may be more resistant to interference 1
• Recent data suggest certain bioluminescent enzyme immunoassay kits maintain high sensitivity even during PPI use 3
• However, standard recommendation remains 2-week PPI discontinuation 1

Endoscopic Biopsy-Based Tests:

• Rapid urease test, histology, and culture all show reduced sensitivity during PPI therapy 1, 4
• Antral biopsies are particularly affected; corpus biopsies may be slightly more reliable but still compromised 4
• 2-week PPI discontinuation applies equally to all biopsy-based methods 1

Serology (IgG antibodies):

• The only test unaffected by PPI therapy 1
• Antibodies remain elevated for months to years regardless of bacterial load changes 1
• Use when PPI discontinuation is not possible 1
• Critical limitation: Cannot distinguish active from past infection, so not suitable for post-treatment test-of-cure 5

Important Caveats

H2-Receptor Antagonists:

• May cause some false-negative results but to a much lesser extent than PPIs 1
• The Maastricht guidelines did not find it necessary to stop H2 blockers before testing when using citric acid 1

Long-term PPI Use:

• No studies have evaluated the optimal washout period after prolonged PPI therapy 1
• In clinical practice, maintain the 2-week discontinuation as minimum, but consider that longer therapy may require extended washout

Antibiotics:

• Also decrease bacterial load and cause false-negative results 1
• Should similarly be discontinued before testing when possible

Choosing Between Testing Methods

When Endoscopy is Already Indicated

• Perform biopsy-based tests (rapid urease test, histology, and/or culture) since the procedure is being done for other clinical reasons 1
• Culture with antibiotic susceptibility testing is particularly valuable in regions with high clarithromycin resistance (>15%) or after treatment failure 1
• Take biopsies from both antrum and corpus to maximize sensitivity, especially if patient was recently on PPIs 4

When Non-Invasive Testing is Appropriate

• Urea breath test is the preferred non-invasive method for diagnosis and post-treatment test-of-cure 5, 6
• Stool antigen test is an acceptable alternative with comparable accuracy 7, 6
• Both require 2-week PPI discontinuation 1
• Use serology only when PPIs cannot be stopped or for initial screening in asymptomatic patients 1, 5

Post-Treatment Test-of-Cure

• Perform testing at least 4 weeks after completing eradication therapy to avoid false-negative results from temporary bacterial suppression 1, 5
• Urea breath test is optimal for this indication 5
• Serology is unsuitable for 6-12 months post-treatment as antibody titers decline slowly 5

Clinical Algorithm Summary

1. Can the patient stop PPIs for 2 weeks?

   • Yes → Proceed with UBT (preferred) or SAT
   • No → Use validated IgG serology (but not for test-of-cure)

2. Is endoscopy clinically indicated?

   • Yes → Perform biopsy-based tests (rapid urease test + histology ± culture)
   • No → Use non-invasive testing (UBT or SAT)

3. Is this for post-treatment confirmation?

   • Wait ≥4 weeks after therapy completion
   • Use UBT or SAT (not serology)
   • Ensure 2-week PPI washout

4. Has first-line treatment failed?

   • Consider culture with susceptibility testing if endoscopy performed 1
   • This guides selection of salvage regimens 8